1Mclaughlin JK,Lipworth L.Epidemiologic aspects of renal cell cancer.Semin Oncol,2000,27,115～123
2Scheltema JM,Romijn JC,van Steenbrugge GJ,et al.Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.Anticancer Res,2001,21(5),3161～6
3Ayesh D,Perera,Elena V.Kleymenova and Cheryl L.Walker 2 Requirement for the von Hippel-Lindau Tumor Suppressor Gene for Functional Epidermal Growth Factor Receptor Blockade by Monoclonal Antibody C225 in Renal Cell Carcinoma.Clinical Cancer Research,2000,6,1518～1523
4Wang LH,Ju DW,Sun Y,et al.The potent antitumor effects of combined P16 gene and GM-CSF gene therapy through efficient induction of antitumor immunity.J Cancer Res Clin Oncol,2001,127(2),101～8
5Uchida T,Gao JP,Wang C,et al.Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.Mol Urol,2001,5(2),71～8
6Hara I,Hara S,Miyake H,et al.Bcl-2 modulates Fas-mediated apoptosis in human renal cell carcinoma cell lines.Int J Oncol,2001,18(6),1181～5
7Zellweger T,Miyake H,July LV,et al.Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.Neoplasia,2001,3(4),360～7
